[ACCI-CAVIE] In Africa, late breast cancer diagnosis is linked not only to the lack of specialized equipment, but also to gaps between the first consultation, diagnostic testing and access to treatment. The World Health Organization’s new guidance for Africa seeks to strengthen this continuum through primary health care, by establishing a more systematic approach to assessing suspected symptoms and referring patients.
Delays That Reveal an Incomplete Care Pathway
The World Health Organization Regional Office for Africa has published a manual entitled Assessment and Diagnostic Workup of Suspected Breast Cancer Cases Using a Primary Health Care Approach. It is intended for nurses, midwives, physicians and other frontline clinicians. The document guides them in identifying suspected symptoms, conducting initial clinical assessments, counselling patients, referring them to specialized services and monitoring their care pathway. It supports the World Health Organization’s Global Breast Cancer Initiative, which aims to promote early detection, timely diagnosis and quality care.
In most countries in the World Health Organization African Region, more than 70% of breast cancer cases are detected at a late stage. The World Health Organization also reports that delays of six months or more between the onset of symptoms and access to appropriate care remain common. The manual therefore prioritizes early diagnosis of symptomatic women, particularly in settings where health systems do not yet have the capacity to implement population-wide mammography screening.
Primary Health Care at the Start of the Pathway
The World Health Organization’s guidance confirms that primary health centres cannot be reduced to points of awareness or first consultation. They must serve as the entry point to a structured care pathway: symptom recognition, clinical examination, counselling, rapid referral, appointment follow-up and continuity of care through imaging, biopsy, pathology, confirmed diagnosis and treatment.
The performance of this pathway depends on several links working together: trained healthcare workers, accessible imaging services, availability of sampling and pathology services, reagents, sample transportation logistics, referral mechanisms, medical records, financing for diagnostic tests and psychosocial support. The World Health Organization notably highlights fear, stigma, distance, cost of care and fragmented services as factors contributing to delays and loss to follow-up.
A Signal of Health System Structuring
For the African Center for Competitive Intelligence (CAVIE), the publication is a signal that the breast cancer diagnostic pathway is becoming more structured. It does not automatically create a market, but establishes an operational reference that Ministries of Health, training institutions, hospitals and development partners are expected to adapt and implement. It therefore makes needs related to training, referral pathways, diagnostic capacity, health data and service coordination more visible.
Competitive Intelligence should now focus on the decisions that follow: integration of the guidance into national cancer control policies, dedicated budgets, training programmes, the creation or strengthening of referral centres, equipment procurement, reagent availability, digital pathology projects and partnerships with the private sector. These decisions will help identify the countries and territories where the pathway moves from a reference framework to actual investments, contracts and service provision.
Operational Recommendations
Health authorities would benefit from mapping the actual patient pathway, from the first report of a symptom through diagnosis and treatment. This mapping should measure delays, costs, equipment distribution, specialist availability, supply disruptions, geographical barriers and loss to follow-up. It would help direct investment towards the links that most frequently delay the rapid confirmation of suspected cases.
Companies, hospitals, laboratories, insurers and digital-sector stakeholders can position themselves around complementary functions: continuing training for healthcare workers, biomedical maintenance, the supply of reagents and consumables, secure transportation of samples, telemedicine, referral systems, appointment management and patient follow-up tools. The value lies less in supplying a single piece of equipment than in making the entire pathway faster, more accessible and better coordinated.
Implementation as a Key Challenge
The World Health Organization’s guidance for Africa will only produce results if it is translated into concrete capabilities: trained personnel, functional referral pathways, access to imaging and pathology, availability of diagnostic tests and patient follow-up. For CAVIE, decisions taken on these levers will help identify the countries where a breast cancer diagnostic pathway is effectively taking shape, as well as the partnerships and service needs that will emerge from it.
The Editorial Staff